104 related articles for article (PubMed ID: 32391417)
21.
Tasian SK
Haematologica; 2023 Jul; 108(7):1713-1714. PubMed ID: 37392046
[No Abstract] [Full Text] [Related]
22. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy.
Watanabe A; Inukai T; Kagami K; Abe M; Takagi M; Fukushima T; Fukushima H; Nanmoku T; Terui K; Ito T; Toki T; Ito E; Fujimura J; Goto H; Endo M; Look T; Kamps M; Minegishi M; Takita J; Inaba T; Takahashi H; Ohara A; Harama D; Shinohara T; Somazu S; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2019 Sep; 8(11):5274-5288. PubMed ID: 31305009
[TBL] [Abstract][Full Text] [Related]
23. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
Qian M; Zhang H; Kham SK; Liu S; Jiang C; Zhao X; Lu Y; Goodings C; Lin TN; Zhang R; Moriyama T; Yin Z; Li Z; Quah TC; Ariffin H; Tan AM; Shen S; Bhojwani D; Hu S; Chen S; Zheng H; Pui CH; Yeoh AE; Yang JJ
Genome Res; 2017 Feb; 27(2):185-195. PubMed ID: 27903646
[TBL] [Abstract][Full Text] [Related]
24. TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors.
Inukai T; Inaba T; Dang J; Kuribara R; Ozawa K; Miyajima A; Wu W; Look AT; Arinobu Y; Iwasaki H; Akashi K; Kagami K; Goi K; Sugita K; Nakazawa S
Blood; 2005 Jun; 105(11):4437-44. PubMed ID: 15665112
[TBL] [Abstract][Full Text] [Related]
25. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL.
Hunger SP; Devaraj PE; Foroni L; Secker-Walker LM; Cleary ML
Blood; 1994 May; 83(10):2970-7. PubMed ID: 8180393
[TBL] [Abstract][Full Text] [Related]
26. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
[TBL] [Abstract][Full Text] [Related]
27. Durable remissions in
Mouttet B; Vinti L; Ancliff P; Bodmer N; Brethon B; Cario G; Chen-Santel C; Elitzur S; Hazar V; Kunz J; Möricke A; Stein J; Vora A; Yaman Y; Schrappe M; Anak S; Baruche A; Locatelli F; von Stackelberg A; Stanulla M; Bourquin JP
Haematologica; 2019 Jun; 104(6):e244-e247. PubMed ID: 30765470
[No Abstract] [Full Text] [Related]
28. Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.
Garg S; Reyes-Palomares A; He L; Bergeron A; Lavallée VP; Lemieux S; Gendron P; Rohde C; Xia J; Jagdhane P; Müller-Tidow C; Lipka DB; Imren S; Humphries RK; Waskow C; Vick B; Jeremias I; Richard-Carpentier G; Hébert J; Sauvageau G; Zaugg JB; Barabé F; Pabst C
Blood; 2019 Jul; 134(3):263-276. PubMed ID: 31076446
[No Abstract] [Full Text] [Related]
29. A t(17;19)(q22;p13.3) Involving TCF3, a t(1;9)(p13;p13), and a 5' IGH Deletion in a Case of Adult B-cell Acute Lymphoblastic Leukemia.
Chow R; Shabsovich D; Schiller G; Kallen M; Tirado CA
J Assoc Genet Technol; 2016; 42(1):6-14. PubMed ID: 27183380
[TBL] [Abstract][Full Text] [Related]
30. Impact of TCF3 rearrangement on CNS relapse in egyptian pediatric acute lymphoblastic leukemia.
ElGendi HM; Abdelmaksoud AA; Eissa DG; Abusikkien SA
Pediatr Hematol Oncol; 2014 Oct; 31(7):638-46. PubMed ID: 25116187
[TBL] [Abstract][Full Text] [Related]
31. The advantage of chimeric antigen receptor T cell therapy in pediatric acute lymphoblastic leukemia with E2A-HLF fusion gene positivity: a case series.
Wu S; Lu J; Su D; Yang F; Zhang Y; Hu S
Transl Pediatr; 2021 Mar; 10(3):686-691. PubMed ID: 33880339
[TBL] [Abstract][Full Text] [Related]
32. Sites of instability in the human TCF3 (E2A) gene adopt G-quadruplex DNA structures in vitro.
Williams JD; Fleetwood S; Berroyer A; Kim N; Larson ED
Front Genet; 2015; 6():177. PubMed ID: 26029241
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
[TBL] [Abstract][Full Text] [Related]
34. Enhanced binding of HLF/DBP heterodimers represents one mechanism of PAR protein transactivation of the factor VIII and factor IX genes.
Begbie M; Mueller C; Lillicrap D
DNA Cell Biol; 1999 Feb; 18(2):165-73. PubMed ID: 10073576
[TBL] [Abstract][Full Text] [Related]
35. [A clinical and laboratory study of TCF3-PBX1 positive adult acute lymphoblastic leukemia.].
Zheng JF; Qiu HY; Pan JL; Cen JN; Wu YF; Zhang J; Wu DP; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):16-20. PubMed ID: 20302770
[TBL] [Abstract][Full Text] [Related]
36. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
Yeung J; O'Sullivan E; Hubank M; Brady HJ
Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
[TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.
Barber KE; Harrison CJ; Broadfield ZJ; Stewart AR; Wright SL; Martineau M; Strefford JC; Moorman AV
Genes Chromosomes Cancer; 2007 May; 46(5):478-86. PubMed ID: 17311319
[TBL] [Abstract][Full Text] [Related]
38. E2A basic helix-loop-helix transcription factors in human leukemia.
LeBrun DP
Front Biosci; 2003 May; 8():s206-22. PubMed ID: 12700034
[TBL] [Abstract][Full Text] [Related]
39. A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature.
Tirado CA; Shabsovich D; Yeh L; Pullarkat ST; Yang L; Kallen M; Rao N
Biomark Res; 2015; 3():4. PubMed ID: 25729575
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]